Biomarin Pharmaceutical shares owned by Barclays
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $507k | 534k | 0.95 |
| 2025-06-30 | $361k | 385k | 0.94 |
| 2025-03-31 | $353k | 374k | 0.94 |
| 2024-12-31 | $162k | 174k | 0.93 |
| 2024-09-30 | $523k | 549k | 0.95 |
| 2024-03-31 | $234k | 236k | 0.99 |
| 2023-12-31 | $358k | 347k | 1.03 |
| 2023-06-30 | $316k | 313k | 1.01 |
| 2022-12-31 | $807k | 747k | 1.08 |